Full Press Release Details
to Host Conference Call to Report Third Quarter 2008 Financial
November 12, 2008, 8:00 am EST
Nov. 12 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a
leading provider of vaccines in China, today announced that it will host a
conference call on Tuesday, November 18, 2008 at 8:00 p.m. ET to review the
Company's third quarter financial results for the period ended September 30,
2008 and provide an update on recent corporate developments.
the conference call, please dial 1-877-407-4018 (USA) or 1-201- 689-8471
(international). A replay of the call will be available from 11:00 p.m. ET on
November 18 until December 2, 2008. To access the replay, please dial
1-877-660-6853 (USA) or 1-201-612-7415 (international) and reference the account
number 3055 and the access code 303493.
audio webcast of the call will also be available from the Investors section on
the corporate web site at http://www.sinovac.com . A webcast replay can be
accessed on the corporate website beginning November 18, 2008 and the replay
will remain available for 30 days.
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal
Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional
information about Sinovac is available on its website, http://www.sinovac.com .
To be added to our distribution list, please email: info@sinovac.com
For more information, please contact:
+86-10-8289-0088 x871
Carrington/Janine McCargo
+1-646-536-7017/7033